| Tag | Content |
|---|
EnhancerAtlas ID | HS177-12344 |
Organism | Homo sapiens |
Tissue/cell | SK-N-SH_RA |
Coordinate | chr2:102058370-102059420 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| SOX10 | MA0442.2 | chr2:102059125-102059136 | TCCTTTGTTTT | - | 6.32 | | Sox3 | MA0514.1 | chr2:102059126-102059136 | CCTTTGTTTT | + | 6.02 | | Sox6 | MA0515.1 | chr2:102058788-102058798 | CCATTGTTTT | + | 6.02 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_39690 | chr2:102057623-102059137 | Jurkat | | SE_39690 | chr2:102059143-102060818 | Jurkat | | SE_66502 | chr2:102057623-102059137 | Jurkat | | SE_66502 | chr2:102059143-102060818 | Jurkat |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I101441 | chr2 | 102057900 | 102059757 |
|
Enhancer Sequence | TTGGTATGTT AGCACTTAAG TCTGCCATTT TATTACTTGT TTTCTATTTG TTTCCTTTGG 60
TTCTTCTTCT TCTATTTCTC TTTTCTTGCC TTTCTGAGGA TTAAACAACG TTGAGGACTC 120
TATCTTGATT TAATTGTAGT ATTTTTGAGT ACATCTCTTG GTATAGTTCT CATAGTGGTC 180
ACATGAGTAT TACAATAGAC ACACGTGACT TACCACAGTC TGTTGGTGGT GATGTTTCAC 240
TACTTTGAGT GAGGTGTGGA AATCTTTTTT CCATTTAGGC CTCTTTACCT TCCCCACTTT 300
TAAATATCAT TGTCTCAAGT ACCAGATGGA GGCCTGATTT TTGTTTCATC AAACATGATT 360
CATAGAACTT GTGATGCAAA GGACAGTGTA TTGTATGTAT CCCATATTTC TGCTCTTCCC 420
ATTGTTTTTT CTCTTCTGAT ACTCCAACAT TCCTTCTATT ATCATTTCCT TTCTCTTTGA 480
AAAACTTTCT TTAGCTGATC TCTAAGGGTG AGTCAGCTAG TGGCAAATTT TTTTGGTTTT 540
TCTTTGCCTG GGAATATTTT TATTTCCCTT TCATTCCTGA AAATAAATTT GCTGGATGTA 600
GAAATTGTGG TTGACAGTTC TTATCTCAGC CCTTGAAACC TTTTGTGCCA CTTCCTTCTG 660
GCTTTCTTGG TGGTTTCAAT GATAAATGTG TTGCCATTCA AATCACTGTT ATAGGTAATG 720
TGTTATTTTT CTGCCTGCTT CCAGGGTTTT ATTTTTCCTT TGTTTTTTGT TTTCAAAAGC 780
TTAATTTTCA GAGCCTTTGT GGTGTTGTTT CAGCCTGCTT GGTTTTTCTG GTGCCTCTGG 840
GCCTCCCACT GGTTCCTGCT GGTGCTACCT GAGGAGGGAG AAGGGTTTCC CCAGGCTAGA 900
CCTTGGGACT TCTCTCCATG AGGGAGGTGC TCCTCCTACT GATGCTCCTG GCGGCCTCTG 960
GGGAGCGGAA GAGTGTCAGT CAGGCTGCAG AACAAAGAGG CTTCCTGGAC CAAGAGGCTT 1020
GTTGAAGCTG GGTCTCTCTA GGCAGATCGG 1050
|
